Skip to main content

Table 3 Adervse events following vaccination in patients with AR and CG

From: Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases

 

AR (n = 236)

CG (n = 1545)

P value

AR (n = 236)

CG (n = 1545)

P value

No symptoms

114 (48.3)

968 (62.7)

 < 0.001

141 (59.7)

1166 (75.5)

 < 0.001

Local reaction

75 (31.8)

309 (20.0)

 < 0.001

69 (29.2)

253 (16.4)

 < 0.001

Pain

71 (30.1)

292 (18.9)

 < 0.001

64 (27.1)

232 (15.0)

 < 0.001

Redness

2 (0.8)

8 (0.5)

0.870

3 (1.3)

11 (0.7)

0.610

Swelling

8 (3.4)

26 (1.7)

0.126

9 (3.8)

27 (1.7)

0.064

Pruritus

0

4 (0.3)

1.000

0

3 (0.2)

1.000

Malaise

0

2 (0.1)

1.000

0

1 (0.1)

1.000

Systemic reactions

72 (30.5)

354 (22.9)

0.011

42 (17.8)

172 (11.1)

0.003

Fever

6 (2.5)

28 (1.8)

0.611

5 (2.1)

14 (0.9)

0.177

Chills

4 (1.7)

8 (0.5)

0.103

0

5 (0.3)

1.000

Fatigue

40 (16.9)

151 (9.8)

 < 0.001

21 (8.9)

77 (5.0)

0.014

Headache

5 (2.1)

17 (1.1)

0.316

3 (1.3)

5 (0.3)

0.132

Vertigo

12 (5.1)

50 (3.2)

0.149

6 (2.5)

25 (1.6)

0.312

Somnolence

3 (1.3)

25 (1.6)

0.906

3 (1.3)

10 (0.6)

0.523

Vomiting

4 (1.7)

14 (0.9)

0.436

1 (0.4)

4 (0.3)

0.509

Diarrhea

10 (4.2)

24 (1.6)

0.011

2 (0.8)

14 (0.9)

0.778

Abdominal pain

1 (0.4)

6 (0.4)

1.000

0

3 (0.2)

1.000

Stuffy nose

3 (1.3)

16 (1.0)

0.990

1 (0.4)

10 (0.6)

0.970

Sore throat

6 (2.5)

27 (1.7)

0.559

3 (1.3)

16 (1.0)

0.990

Cough

3 (1.3)

14 (0.9)

0.859

2 (0.8)

9 (0.6)

0.970

Chest pain

0

1 (0.1)

1.000

0

0

1.000

Cardiopalmus

1 (0.4)

3 (0.2)

0.434

1 (0.4)

3 (0.2)

0.434

New or worsened muscle pain

6 (2.5)

15 (1.0)

0.079

4 (1.7)

13 (0.8)

0.370

New or worsened joint pain

0

3 (0.2)

1.000

1 (0.4)

4 (0.3)

0.509

Skin rash

4 (1.7)

19 (1.2)

0.780

2 (0.8)

7 (0.5)

0.762